Solesence (SLSN) reported breakeven Q2 results late Wednesday, compared with earnings of $0.04 per diluted share a year earlier.
Revenue in the three months ended June 30 fell to $15.3 million from $20.4 million a year earlier.
Solesence (SLSN) reported breakeven Q2 results late Wednesday, compared with earnings of $0.04 per diluted share a year earlier.
Revenue in the three months ended June 30 fell to $15.3 million from $20.4 million a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.